Farnesoid-X-receptor expression in monocrotaline-induced pulmonary arterial hypertension and right heart failure

Biochemical and Biophysical Research Communications

Volumn 467, Issue 1, 2015, Pages 164-170

  Ye, Lusi ^a,b   Jiang, Ying ^a   Zuo, Xiaoxia ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

FXR; Heart; Lung; PAH; RHF

Indexed keywords

FARNESOID X RECEPTOR; MESSENGER RNA; MONOCROTALINE; CELL RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; HEART; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMIC PARAMETERS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG PARENCHYMA; MALE; MOLECULAR WEIGHT; MONOCROTALINE-INDUCED PULMONARY HYPERTENSION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; GENE EXPRESSION; GENETICS; HEART FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE; HEART VENTRICLE REMODELING; LUNG; METABOLISM; PULMONARY HYPERTENSION; SPRAGUE DAWLEY RAT; VASCULAR REMODELING;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HEART FAILURE; HEART VENTRICLES; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; LUNG; MALE; MONOCROTALINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; VASCULAR REMODELING; VENTRICULAR REMODELING;

EID: 84944899546     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.09.067     Document Type: Article

References (42)

1. M. Rabinovitch Molecular pathogenesis of pulmonary arterial hypertension J. Clin. Invest. 118 2008 2372 2379
2. K.M. Chin, and L.J. Rubin Pulmonary arterial hypertension J. Am. Coll. Cardiol. 51 2008 1527 1538
3. M. Humbert, N.W. Morrell, S.L. Archer, K.R. Stenmark, M.R. MacLean, I.M. Lang, B.W. Christman, E.K. Weir, O. Eickelberg, N.F. Voelkel, and M. Rabinovitch Cellular and molecular pathobiology of pulmonary arterial hypertension J. Am. Coll. Cardiol. 43 2004 13S 24S
4. T.K. Jeffery, and N.W. Morrell Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension Prog. Cardiovasc. Dis. 45 2002 173 202
5. B.M. Forman, E. Goode, J. Chen, A.E. Oro, D.J. Bradley, T. Perlmann, D.J. Noonan, L.T. Burka, T. McMorris, W.W. Lamph, R.M. Evans, and C. Weinberger Identification of a nuclear receptor that is activated by farnesol metabolites Cell 81 1995 687 693
6. D.J. Parks, S.G. Blanchard, R.K. Bledsoe, G. Chandra, T.G. Consler, S.A. Kliewer, J.B. Stimmel, T.M. Willson, A.M. Zavacki, D.D. Moore, and J.M. Lehmann Bile acids: natural ligands for an orphan nuclear receptor Science 284 1999 1365 1368
7. M. Makishima, A.Y. Okamoto, J.J. Repa, H. Tu, R.M. Learned, A. Luk, M.V. Hull, K.D. Lustig, D.J. Mangelsdorf, and B. Shan Identification of a nuclear receptor for bile acids Science 284 1999 1362 1365
8. C.J. Sinal, M. Tohkin, M. Miyata, J.M. Ward, G. Lambert, and F.J. Gonzalez Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis Cell 102 2000 731 744
9. J. Pu, A. Yuan, P. Shan, E. Gao, X. Wang, Y. Wang, W.B. Lau, W. Koch, X.L. Ma, and B. He Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury Eur. Heart J. 34 2013 1834 1845
10. F. He, J. Li, Y. Mu, R. Kuruba, Z. Ma, A. Wilson, S. Alber, Y. Jiang, T. Stevens, S. Watkins, B. Pitt, W. Xie, and S. Li Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells Circ. Res. 98 2006 192 199
11. D. Bishop-Bailey, D.T. Walsh, and T.D. Warner Expression and activation of the farnesoid X receptor in the vasculature Proc. Natl. Acad. Sci. U. S. A. 101 2004 3668 3673
12. A. Mencarelli, S. Cipriani, B. Renga, C. D'Amore, G. Palladino, E. Distrutti, F. Baldelli, and S. Fiorucci FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity Nutr. Metab. Cardiovasc Dis. 23 2013 94 101
13. T. Kida, T. Murata, M. Hori, and H. Ozaki Chronic stimulation of farnesoid X receptor impairs nitric oxide sensitivity of vascular smooth muscle Am. J. Physiol. Heart Circ. Physiol. 296 2009 H195 H201
14. J. Li, A. Wilson, R. Kuruba, Q. Zhang, X. Gao, F. He, L.M. Zhang, B.R. Pitt, W. Xie, and S. Li FXR-mediated regulation of eNOS expression in vascular endothelial cells Cardiovasc. Res. 77 2008 169 177
15. F. He, Q. Zhang, R. Kuruba, X. Gao, J. Li, Y. Li, W. Gong, Y. Jiang, W. Xie, and S. Li Upregulation of decorin by FXR in vascular smooth muscle cells Biochem. Biophys. Res. Commun. 372 2008 746 751
16. Q. Zhang, F. He, R. Kuruba, X. Gao, A. Wilson, J. Li, T.R. Billiar, B.R. Pitt, W. Xie, and S. Li FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells Cardiovasc. Res. 77 2008 560 569
17. Y.T. Li, K.E. Swales, G.J. Thomas, T.D. Warner, and D. Bishop-Bailey Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration Arterioscler. Thromb. Vasc. Biol. 27 2007 2606 2611
18. M. Hamblin, L. Chang, Y. Fan, J. Zhang, and Y.E. Chen PPARs and the cardiovascular system Antioxid. Redox Signal. 11 2009 1415 1452
19. J. Li, and N. Wang Peroxisome proliferator-activated receptor-gamma in vascular biology Cardiovasc. Hematol. Disord. Drug Targets 7 2007 109 117
20. G. Hansmann, and R.T. Zamanian PPARgamma activation: a potential treatment for pulmonary hypertension Sci. Transl. Med. 1 2009 12ps14
21. J. Tian, A. Smith, J. Nechtman, R. Podolsky, S. Aggarwal, C. Snead, S. Kumar, M. Elgaish, P. Oishi, A. Goerlach, S. Fratz, J. Hess, J.D. Catravas, A.D. Verin, J.R. Fineman, J.X. She, and S.M. Black Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension Physiol. Genomics 40 2009 48 60
22. G. Hansmann, R.A. Wagner, S. Schellong, V.A. Perez, T. Urashima, L. Wang, A.Y. Sheikh, R.S. Suen, D.J. Stewart, and M. Rabinovitch Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation Circulation 115 2007 1275 1284
23. D.E. Green, R.L. Sutliff, and C.M. Hart Is peroxisome proliferator-activated receptor gamma (PPARgamma) a therapeutic target for the treatment of pulmonary hypertension? Pulm. Circ. 1 2011 33 47
24. Y. Matsuda, Y. Hoshikawa, S. Ameshima, S. Suzuki, Y. Okada, T. Tabata, T. Sugawara, Y. Matsumura, and T. Kondo Effects of peroxisome proliferator-activated receptor gamma ligands on monocrotaline-induced pulmonary hypertension in rats Nihon Kokyuki Gakkai Zasshi 43 2005 283 288
25. M. Rabinovitch PPARgamma and the pathobiology of pulmonary arterial hypertension Adv. Exp. Med. Biol. 661 2010 447 458
26. J.T. Crossno Jr., K.G. Morris Jr., and D.J. Klemm Attenuation of hypoxia-induced pulmonary artery remodeling by a peroxisome proliferator-activated receptor-gamma agonist Chest 128 2005 580S
27. D. Zhang, G. Wang, D. Han, Y. Zhang, J. Xu, J. Lu, S. Li, X. Xie, L. Liu, L. Dong, and M. Li Activation of PPAR-gamma ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats Life Sci. 98 2014 39 43
28. G. Hansmann, V.A. de Jesus Perez, T.P. Alastalo, C.M. Alvira, C. Guignabert, J.M. Bekker, S. Schellong, T. Urashima, L. Wang, N.W. Morrell, and M. Rabinovitch An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension J. Clin. Invest. 118 2008 1846 1857
29. T.P. Alastalo, M. Li, J. Perez Vde, D. Pham, H. Sawada, J.K. Wang, M. Koskenvuo, L. Wang, B.A. Freeman, H.Y. Chang, and M. Rabinovitch Disruption of PPARgamma/beta-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival J. Clin. Invest 121 2011 3735 3746
30. K. Gong, D. Xing, P. Li, B. Aksut, N. Ambalavanan, Q. Yang, S.E. Nozell, S. Oparil, and Y.F. Chen Hypoxia induces downregulation of PPAR-gamma in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-beta signaling Am. J. Physiol. Lung Cell. Mol. Physiol. 301 2011 L899 L907
31. P. Li, Y. Liu, B. Yi, G. Wang, X. You, X. Zhao, R. Summer, Y. Qin, and J. Sun MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1 Cardiovasc. Res. 99 2013 185 193
32. J. Gien, N. Tseng, G. Seedorf, G. Roe, and S.H. Abman Peroxisome proliferator activated receptor-gamma-Rho-kinase interactions contribute to vascular remodeling after chronic intrauterine pulmonary hypertension Am. J. Physiol. Lung Cell. Mol. Physiol. 306 2014 L299 L308
33. Y. Liu, X.Y. Tian, G. Mao, X. Fang, M.L. Fung, J.Y. Shyy, Y. Huang, and N. Wang Peroxisome proliferator-activated receptor-gamma ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor Hypertension 60 2012 1471 1478
34. X. Lu, T.C. Murphy, M.S. Nanes, and C.M. Hart PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B Am. J. Physiol. Lung Cell. Mol. Physiol. 299 2010 L559 L566
35. Y. Liu, X.Y. Tian, Y. Huang, and N. Wang Rosiglitazone attenuated endothelin-1-induced vasoconstriction of pulmonary arteries in the rat model of pulmonary arterial hypertension via differential regulation of ET-1 receptors PPAR Res. 2014 2014 374075
36. K. Otte, H. Kranz, I. Kober, P. Thompson, M. Hoefer, B. Haubold, B. Remmel, H. Voss, C. Kaiser, M. Albers, Z. Cheruvallath, D. Jackson, G. Casari, M. Koegl, S. Paabo, J. Mous, C. Kremoser, and U. Deuschle Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol Mol. Cell. Biol. 23 2003 864 872
37. S.H. Sheikh Abdul Kadir, M. Miragoli, S. Abu-Hayyeh, A.V. Moshkov, Q. Xie, V. Keitel, V.O. Nikolaev, C. Williamson, and J. Gorelik Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes PLoS One 5 2010 e9689
38. S. Yasuda, H. Kobayashi, M. Iwasa, I. Kawamura, S. Sumi, B. Narentuoya, T. Yamaki, H. Ushikoshi, K. Nishigaki, K. Nagashima, G. Takemura, T. Fujiwara, H. Fujiwara, and S. Minatoguchi Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction Am. J. Physiol. Heart Circ. Physiol. 296 2009 H1558 H1565
39. Y. Ye, Z. Hu, Y. Lin, C. Zhang, and J.R. Perez-Polo Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury Cardiovasc. Res. 87 2010 535 544
40. A. Mencarelli, S. Cipriani, B. Renga, C. D'Amore, G. Palladino, E. Distrutti, F. Baldelli, and S. Fiorucci FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity Nutr. Metab. Cardiovasc. Dis. 23 2013 94 101
41. L. Zhang, T. Li, D. Yu, B.M. Forman, and W. Huang FXR protects lung from lipopolysaccharide-induced acute injury Mol. Endocrinol. 26 2012 27 36
42. S. Khurana, J.P. Raufman, and T.L. Pallone Bile acids regulate cardiovascular function Clin. Transl. Sci. 4 2011 210 218